Carbozar 150mg Injection
Marketer
RPG Life Sciences Ltd
Salt Composition
Carboplatin (150mg)
Overview Carbozar 150mg Injection
Oncaspar 150mg Injection treats ovarian and small cell lung cancers by inhibiting or reducing cancer cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdosage can lead to severe adverse effects. While therapeutic benefits may not be apparent for weeks or months, discontinuation should only occur upon your doctor's instruction. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can lower blood cell counts (red and white), increasing infection and bleeding risks. Report fever, sore throat, chills, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitoring blood cell counts, heart function, liver health, and uric acid levels are necessary. Allergic reactions (skin rash, itching, breathing difficulties) must be reported. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding. Both partners should employ reliable contraception throughout the treatment period to prevent conception.
Uses of Carbozar 150mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Carbozar 150mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Carbozar 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Carbozar 150mg Injection:
The medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.
How Carbozar 150mg Injection works:
OncoZar 150mg Injection is a chemotherapeutic agent targeting cancerous cells. Its mechanism involves disrupting the DNA and RNA of these cells, thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Carbozar 150mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Carbozar 150mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in exceptional, life-threatening circumstances where the potential benefits outweigh the known hazards, as determined by a physician. Seek medical advice before use.
Breast feedingUNSAFE
Administering Carbozar 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Carbozar 150mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is inadvisable if these side effects manifest.
KidneyCAUTION
Exercise caution when administering Carbozar 150mg Injection to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician before use. Carbozar 150mg Injection is contraindicated in patients exhibiting severe renal insufficiency. Routine monitoring of renal parameters is advisable during treatment.
LiverSAFE IF PRESCRIBED
The use of Carbozar 150mg Injection in patients with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary for this population. Physician consultation is recommended.
What if you forget to take Carbozar 150mg Injection :
Omit a Carbozar 150mg Injection dose? Seek your physician's advice.
Facts to Know About Carbozar 150mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Platinum-Based Anticancer Agents |
3,018 People bought this recently